Cellular Orthopedics Blog
The Recreational Impact of Biologics: Stem Cells, Growth Factors, and Platelet Rich Plasma
This past Sunday morning, I was reading the Chicago Tribune sports section to learn about the pundits’ opinions regarding the basketball game played by Duke and North Carolina on Saturday night, one of the most amazing basketball games I have ever seen, (incidentally,...
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use
FDA Warns About Stem Cell Therapies Some patients may be vulnerable to stem cell treatments that are illegal and potentially harmful. September,2017 FDA News Release FDA sends warning to company for selling unapproved umbilical cord blood and umbilical cord products...
A Regenerative Medicine Potpourri
I have been invited to participate in a Crain’s Chicago Business Orthopedic Roundtable discussion scheduled to appear in Crain’s on 02/24/2020. My focus will be on Orthobiologics and Cellular orthopedics. As readers of this blog are aware, I personally underwent...
My Orthopedic Recommendation for Two Recreational Middle-Aged Athletes
I make this orthopedic recommendation as emeritus professor of orthopedic surgery at a major medical center where I was director of the joint replacement program and where I performed close to 20,000 knee and hip replacements. First and foremost, try to postpone a...
Attention ‘Stem Cell Charlatans and Birth Tissue Bad Actors/Camp Followers’: The End Is Coming
DEFENSE HEALTH AGENCY 7700 ARLINGTON BOULEVARD, SUITE 5101 FALLS CHURCH, VIRGINIA 22042-5101 MEMORANDUM FOR DEPUTY CHIEF, READINESS AND HEALTH, BUREAU OF MEDICINE AND SURGERY DEPUTY CHIEF OF STAFF G-3/5/7, OFFICE OF THE SURGEON GENERAL DIRECTOR, MEDICAL OPERATIONS AND...
Dr. Mitchell Sheinkop Co-Authors Article Published in the International Journal of Recent Scientific Research
This excerpt is taken from the full article, which can be read here. Copyright © Mitchell B Sheinkop and Maxwell Dordevic,2019, Abstract This case report will introduce the concept of using an acellular mesenchymal stem cell (MSC) derived extracellular vesicle isolate...
My Opinion Regarding the Current Use of Biologics and Cellular Therapies
The complexities inherent in biologics, cellular therapies, and stem cells as therapeutic entities are being been addressed at a number of levels. Thoughtful editorials, consensus statements, and even actions by state licensing boards, the FDA and the FTC for...
Stems Cells: Promise and Reality
Saturday evening, we returned from four days of fly fishing for Bone Fish, Permit, Jacks, Tarpon and Snook in Punta Allen, Mexico, three hours south of Cancun. The adventure involves standing on the front of a boat for up to six hours a day, with an occasional break....
Advances in Regenerative Medicine Continue
The progress in the emerging discipline, Orthobiologics, in part, is the result of the FDA and FTC taking on a stronger oversite role; but additionally, the data I gather contributes to these scientific advances. I will elaborate in this blog. In order to be FDA...
Orthobiologics Informed Consent, Continued
Let me think, where did I leave off last week? Is there any chance of postponing, or perhaps avoiding a joint replacement, either total or partial? The answer to the question is why I “graduated” from joint replacement to the new discipline of Cellular Orthopedics or...
An Informed Consent for Orthobiologics
This past Saturday and Sunday, we had the pleasure of hosting our nephew and grandniece during a college visit. The nephew is a 52-year-old extremely athletic man who initially had complained of pain and swelling in his left knee ten years ago. At the time, he had...
Orthobiologic Times Are Changing
November 20, 2019 Dear Mitchell B Sheinkop, MD, FAAOS, On behalf of the American Academy of Orthopaedic Surgeons’ Board of Directors, I am pleased to officially announce the Academy’s strategic investment in the field of biologics. As the world’s largest medical...